These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 36284386

  • 1. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G, Shang C, Zhu Y, Xiu Z, Li Y, Yang X, Ge C, Han J, Jin N, Li Y, Li X, Fang J.
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [Abstract] [Full Text] [Related]

  • 2. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
    Song G, Fang J, Shang C, Li Y, Zhu Y, Xiu Z, Sun L, Jin N, Li X.
    Exp Cell Res; 2021 Dec 15; 409(2):112926. PubMed ID: 34793774
    [Abstract] [Full Text] [Related]

  • 3. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G, Singh RK, Iqbal MA, Saini SK, Tiku AB, Bamezai RNK.
    J Biol Chem; 2017 Sep 15; 292(37):15561-15576. PubMed ID: 28778925
    [Abstract] [Full Text] [Related]

  • 4. KAT8 enhances the resistance of lung cancer cells to cisplatin by acetylation of PKM2.
    Li Z, Lu X, Zhang J, Liu T, Xu M, Liu S, Liang J.
    Anticancer Drugs; 2024 Sep 01; 35(8):732-740. PubMed ID: 38771737
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.
    Chu B, Wang J, Wang Y, Yang G.
    Mol Med Rep; 2015 Sep 01; 12(3):4358-4363. PubMed ID: 26082202
    [Abstract] [Full Text] [Related]

  • 8. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
    Zhang C, Huang Z.
    Mol Biotechnol; 2024 Jun 01; 66(6):1446-1457. PubMed ID: 37294531
    [Abstract] [Full Text] [Related]

  • 9. PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Ma C, Feng Y, Zhong K, Wei J.
    Neurol Res; 2024 Jul 01; 46(7):583-592. PubMed ID: 38797679
    [Abstract] [Full Text] [Related]

  • 10. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, Hu Q, Liu N, You Y.
    Oncotarget; 2015 May 30; 6(15):13006-18. PubMed ID: 25948776
    [Abstract] [Full Text] [Related]

  • 11. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
    Yu Z, Huang L, Qiao P, Jiang A, Wang L, Yang T, Tang S, Zhang W, Ren C.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):953-958. PubMed ID: 27045080
    [Abstract] [Full Text] [Related]

  • 12. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
    Hu Y, Mu H, Deng Z.
    Cell Biol Int; 2021 Oct 13; 45(10):2063-2073. PubMed ID: 34196069
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J, Zhang D, Han Y, Wang Z, Ma C.
    J Cell Biochem; 2019 Oct 13; 120(10):17303-17311. PubMed ID: 31106485
    [Abstract] [Full Text] [Related]

  • 14. Sanqi oral solution ameliorates renal fibrosis by suppressing fibroblast activation via HIF-1α/PKM2/glycolysis pathway in chronic kidney disease.
    Hu D, Wang L, Zhang Y, Liu X, Lu Z, Li H.
    J Ethnopharmacol; 2024 Dec 05; 335():118679. PubMed ID: 39121930
    [Abstract] [Full Text] [Related]

  • 15. A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2/mTOR pathway in human ovarian cancer cells.
    Tae IH, Son JY, Lee SH, Ahn MY, Yoon K, Yoon S, Moon HR, Kim HS.
    Int J Biol Sci; 2020 Dec 05; 16(11):1901-1916. PubMed ID: 32398958
    [Abstract] [Full Text] [Related]

  • 16. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
    Xiaoyu H, Yiru Y, Shuisheng S, Keyan C, Zixing Y, Shanglin C, Yuan W, Dongming C, Wangliang Z, Xudong B, Jie M.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818780063. PubMed ID: 29916308
    [Abstract] [Full Text] [Related]

  • 17. Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2.
    Wang RH, Chen PR, Chen YT, Chen YC, Chu YH, Chien CC, Chien PC, Lo SY, Wang ZL, Tsou MC, Chen SY, Chiu GS, Chen WL, Wu YH, Wang LH, Wang WC, Lin SY, Kung HJ, Wang LH, Cheng HC, Lin KT.
    Nat Commun; 2024 Aug 29; 15(1):7463. PubMed ID: 39198443
    [Abstract] [Full Text] [Related]

  • 18. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X, Tan F, Cao X, Cao Z, Li B, Shen Z, Tian Y.
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan 02; 52(1):9-17. PubMed ID: 31867609
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.
    Guo W, Zhang Y, Chen T, Wang Y, Xue J, Zhang Y, Xiao W, Mo X, Lu Y.
    J Cancer Res Clin Oncol; 2011 Jan 02; 137(1):65-72. PubMed ID: 20336315
    [Abstract] [Full Text] [Related]

  • 20. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway.
    Yang Y, Li S, Shi W, Jin G, Guo D, Li A, Wang B, Lu B, Feng S.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113247. PubMed ID: 39321706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.